Actuate Therapeutics, Inc. ACTU
0.68
0.06
9.68%
as of 25 Sep
- Market cap
- $15.9M
- P/E
- 0.0×
Follow ACTU
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
Current Ratio |
2.39 | 1.05 | 0.43 |
Net Debt/EBITDA |
0.59 | 0.34 | 0.12 |
Debt/Assets |
0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | — |
Operating CF/Net income |
0.86 | 0.80 | 0.87 |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| (553.75%) | 54.83% | 0.00% | |
| (190.35%) | (443.16%) | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(280.07%) | (6,730.46%) | 630.44% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.91) | (2.61) | (15.07) |
Cash per Share |
0.63 | 1.03 | 2.06 |
Shareholders Equity per Share |
0.38 | 0.01 | (69.43) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
0.38 | 0.01 | (69.43) |
Free Cash Flow |
(19.21) | (21.84) | (21.63) |
Working Capital |
7.94 | 0.41 | (3.92) |
Net Current Asset Value |
7.53 | (0.01) | (99.63) |
| Other line items | |||
Quick Ratio |
2.31 | 0.98 | 0.43 |
Cash ROIC |
(91.10%) | (249.75%) | 22.37% |
Accounts Payable Turnover |
0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.91) | (2.61) | (15.07) |
Capex per Share |
0.00 | 0.00 | 0.00 |
Average Payables |
1.72 | 2.67 | — |
Average Assets |
11.68 | 6.16 | — |
Average Common Equity |
4.01 | (49.76) | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% |
Columns are period end dates